Filter
2197
Filtered Results: 2197
Text search:
costos
TB
Featured
Recommendations
177
New Publications
623
Language
Document type
No document type
1355
Studies & Reports
324
Guidelines
253
Strategic & Response Plan
98
Manuals
97
Training Material
23
Fact sheets
22
Situation Updates
12
Infographics
7
Brochures
3
Resource Platforms
3
Countries / Regions
India
92
Kenya
85
Global
80
South Africa
62
Western and Central Europe
53
Uganda
43
Ethiopia
43
Zambia
42
Nepal
39
Malawi
39
Sierra Leone
38
Myanmar / Burma
38
Africa
37
Latin America and the Carribbean
36
Nigeria
34
Liberia
33
Tanzania
31
Eastern Europe
31
Ghana
29
Rwanda
28
Bangladesh
25
Cambodia
24
Colombia
23
Ukraine
23
Paraguay
23
Namibia
22
Mozambique
21
Asia
21
South–East Asia Region
20
Lesotho
18
Peru
18
Zimbabwe
16
Argentina
16
Venezuela
13
Bolivia
13
Botswana
13
Indonesia
13
Philippines
12
El Salvador
11
East and Southern Africa
10
Brazil
10
Syria
9
Congo, Democratic Republic of
8
Senegal
7
Germany
7
Pakistan
7
Benin
6
Haiti
6
Georgia
6
Burkina Faso
5
Guinea
5
West and Central Africa
5
Middle East and North Africa
5
Western Pacific Region
5
Russia
5
South Sudan
5
Thailand
4
Cameroon
4
Albania
4
Eastern Europe and Central Asia
4
Vietnam
4
Sudan
4
Timor Leste/ East Timor
3
Mexico
3
Laos
3
Armenia
3
Jordan
3
North America
3
Southern Africa
3
Moldova
3
Poland
3
Ecuador
3
North Macedonia
2
Tajikistan
2
Chile
2
Iran
2
Hungary
2
Lebanon
2
Nicaragua
2
Sri Lanka
2
Yemen
2
Romania
2
Central African Republic
2
Honduras
2
Iraq
2
Eswatini/ Swaziland
2
North Korea
1
Serbia
1
China
1
Singapore
1
Estonia
1
Afghanistan
1
Burundi
1
Morocco
1
Bulgaria
1
USA
1
Dominican Republic
1
Guinea-Bissau
1
Ireland
1
Saudi Arabia
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Maldives
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Côte d’Ivoire / Ivory Coast
1
Papua New Guinea
1
Greece
1
Angola
1
Chad
1
Bhutan
1
Somalia
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
927
Clinical Guidelines
156
Public Health
107
Key Resources
58
Women & Child Health
51
Pharmacy & Technologies
23
Capacity Building
20
Toolboxes
TB
428
HIV
276
AMR
90
COVID-19
75
Mental Health
69
NTDs
67
Disability
39
Pharmacy
36
Health Financing Toolbox
36
Caregiver
35
Global Health Education
35
NCDs
30
Planetary Health
28
Refugee
27
Conflict
26
Polio
22
Ebola & Marburg
21
Rapid Response
19
Natural Hazards
18
Social Ethics
6
Specific Hazards
5
Cholera
3
Zika
3
South Sudan
1
Malaria
1
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0169530 February 16, 2017
Community health workers (CHWs) enable marginalised communities, often experiencing structural poverty, to access healthcare. Trust, important in all patient–provider relationships, is difficult to build in such
communities, particularly when stigma associated with HIV/AIDS, tuberculosis and now ...
Taenia saginata is a zoonotic tapeworm that is of economic importance in countries where cattle are kept. The parasite is transmitted from human tapeworm carriers (taeniosis) to bovines (cysticercosis) by excretion of eggs or proglottids containing eggs into the environment via the stool. Bovines ca...
The ICAT is a simple and practical approach for assessing the adequacy of existing infection prevention and control practices and provides specific recommendations for improving practices and monitoring their effectiveness over time
UNAIDS 2018 / Guidance
Guidance for policy-makers, and people living with, at risk of or affected by HIV
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
For biological agents, the publication covers 11 bacteria,
fungi and viruses listed by states parties to the Biological
Weapons Convention in declarations of past offensive
research and development programmes, or considered of
special concern for possible use in terrorism. All of these
agents c...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
The Global vector control response 2017–2030 (GVCR) provides a new strategy to strengthen vector control worldwide through increased capacity, improved surveillance, better coordination and integrated action across sectors and diseases.
In May 2017, the World Health Assembly adopted resolutio...
In May 2017, the World Health Assembly adopted resolutio...
The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.
WHO recommends that a...
WHO recommends that a...
The Demographic Dividend study on Rwanda assessed the socio-economic and human development potential of our country in the short, medium and long-term period using a comprehensive approach. It generated relevant policy and programme information to guide a well-informed polciy required to propel Rwan...
The current trend in AMR in Uganda and globally is rising and calls for immediate action. The 71st UN General Assembly (UNGA), the 68th World Health Assembly, and organizations including the World Health Organization (WHO), the Food and Agriculture Organization (FAO), and the World Organization for ...
The 2011-2012 National Annual Report on HIV program presents the progress in implementing the strategies and activities articulated in the National Strategic Plan on HIV and AIDS 2009-2012, commonly referred to as the HIV NSP.
The main objective of this guidance is to provide scientific advice, based on an evidence-based assessment of targeted public health interventions, to facilitate effective screening and vaccination for priority infectious diseases among newly arrived migrant populations to the EU/EEA. It is intended...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
htb supplement: 2018 Vol 19:(1)
New drugs in development
July 2018
www.i-Base.info
